OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and Safety
Simona Lattanzi, Eugen Trinka, Claudia Altamura, et al.
Neurology and Therapy (2022) Vol. 11, Iss. 3, pp. 1235-1252
Open Access | Times Cited: 12
Simona Lattanzi, Eugen Trinka, Claudia Altamura, et al.
Neurology and Therapy (2022) Vol. 11, Iss. 3, pp. 1235-1252
Open Access | Times Cited: 12
Showing 12 citing articles:
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
Roberta Messina, Eva‐Maria Huessler, Francesca Puledda, et al.
Cephalalgia (2023) Vol. 43, Iss. 3
Open Access | Times Cited: 76
Roberta Messina, Eva‐Maria Huessler, Francesca Puledda, et al.
Cephalalgia (2023) Vol. 43, Iss. 3
Open Access | Times Cited: 76
Synthetic Approaches to the New Drugs Approved During 2021
Emma L. McInturff, Scott P. France, Carolyn A. Leverett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10150-10201
Closed Access | Times Cited: 15
Emma L. McInturff, Scott P. France, Carolyn A. Leverett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10150-10201
Closed Access | Times Cited: 15
Nitrogen-Based Organofluorine Functional Molecules: Synthesis and Applications
Shuai Liu, Jun Zhou, Lu Yu, et al.
Chemical Reviews (2025)
Closed Access
Shuai Liu, Jun Zhou, Lu Yu, et al.
Chemical Reviews (2025)
Closed Access
Competing treatments for migraine: a headache for decision-makers
Hema Mistry, Seyran Naghdi, Martin Underwood, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Hema Mistry, Seyran Naghdi, Martin Underwood, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic review
Seyran Naghdi, Martin Underwood, Anna Brown, et al.
BMJ Neurology Open (2024) Vol. 6, Iss. 1, pp. e000616-e000616
Open Access | Times Cited: 3
Seyran Naghdi, Martin Underwood, Anna Brown, et al.
BMJ Neurology Open (2024) Vol. 6, Iss. 1, pp. e000616-e000616
Open Access | Times Cited: 3
Efficacy and safety of atogepant, a small molecule CGRP receptor antagonist, for the preventive treatment of migraine: a systematic review and meta-analysis
Min Hou, Xiaofeng Luo, Shuangshuang He, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Min Hou, Xiaofeng Luo, Shuangshuang He, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Adverse events associated with Atogepant: a faers-based pharmacovigilance analysis
Ying Zhang, Shengzhu Sun, Y. Wang
Expert Opinion on Drug Safety (2024), pp. 1-7
Closed Access | Times Cited: 3
Ying Zhang, Shengzhu Sun, Y. Wang
Expert Opinion on Drug Safety (2024), pp. 1-7
Closed Access | Times Cited: 3
Efficacy and safety of eptinezumab as preventive treatment for episodic/chronic migraine: A systematic review and meta‐analysis
Yusak Mangara Tua Siahaan, Vinson Hartoyo, Timotius Ivan Hariyanto
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 11, pp. 1156-1168
Closed Access | Times Cited: 9
Yusak Mangara Tua Siahaan, Vinson Hartoyo, Timotius Ivan Hariyanto
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 11, pp. 1156-1168
Closed Access | Times Cited: 9
Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults
Adarsh Raja, Rabia Asim, Muhammad Hamza Shuja, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Adarsh Raja, Rabia Asim, Muhammad Hamza Shuja, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease
Panjamaporn Sangwung, Joseph D. Ho, Tessa Siddall, et al.
AJP Endocrinology and Metabolism (2024) Vol. 327, Iss. 5, pp. E600-E615
Closed Access
Panjamaporn Sangwung, Joseph D. Ho, Tessa Siddall, et al.
AJP Endocrinology and Metabolism (2024) Vol. 327, Iss. 5, pp. E600-E615
Closed Access
Efficacy and Tolerability of Erenumab and Topiramate for Prevention of Chronic Migraine: A Retrospective Cohort Study
Eslam El Nebrisi, Zainaba Suaad Ahmed Ruwayya, Dalya Ibrahim Alzayori, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1684-1684
Open Access
Eslam El Nebrisi, Zainaba Suaad Ahmed Ruwayya, Dalya Ibrahim Alzayori, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1684-1684
Open Access
Safety and Efficacy of Atogepant for the Preventive Treatment of Migraines in Adults: A Systematic Review and Meta-Analysis
Abdulrahim Saleh Alrasheed, Taif Mansour Almaqboul, Reem Ali Alshamrani, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6713-6713
Open Access
Abdulrahim Saleh Alrasheed, Taif Mansour Almaqboul, Reem Ali Alshamrani, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6713-6713
Open Access
